Strattera ® (atomoxetine)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Strattera Summary of Product Characteristics (SmPC)

Strattera® (atomoxetine): Excipients

Strattera preparations contain additional ingredients.

List of excipients

Capsules

The capsules contain:

Starch, pregelatinised (Maize)

Dimeticone

Capsule shell:

Sodium laurilsulfate

Gelatin

Capsule shell cap colourants:

10 mg: Titanium dioxide E 171

18 mg: Yellow iron oxide E172

25 mg, 40 mg, and 60 mg: FD&C Blue 2 (Indigo Carmine) E132 and Titanium dioxide E 171

80 mg and 100 mg: Yellow iron oxide E172, Red iron oxide E172, Titanium dioxide E171

Capsule Shell Body colourants:

60 mg: Yellow iron oxide E172

10 mg, 18 mg, 25 mg and 80 mg: Titanium dioxide E 171

40 mg: FD&C Blue 2 (Indigo Carmine) E132 and Titanium dioxide E 171

100 mg: Yellow iron oxide E172, Red iron oxide E172, Titanium dioxide E171

Edible Black Ink SW-9008 (containing Shellac and Black Iron Oxide E172) or Edible Black Ink SW- 9010 (containing Shellac and Black Iron Oxide E172).

Oral solution

Sodium benzoate (E211)

Sodium dihydrogen phosphate dihydrate

Phosphoric acid, dilute

Sorbitol, liquid (crystallising) (E420)

Xylitol

Artificial raspberry flavouring

Sucralose

Sodium hydroxide (for pH adjustment)

Purified water

REFERENCE

Strattera Summary of Product Characteristics

Date of Last Review: November 02, 2018

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question